Reasons to Hold Tandem Diabetes Stock in Your Portfolio Now
Innovations and a robust diabetes market outlook raise investors' optimism for TNDM.
https://www.zacks.com/stock/news/2330816/reasons-to-hold-tandem-diabetes-stock-in-your-portfolio-now
Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.
DexCom, Inc. (DXCM) specializes in continuous glucose monitoring systems for diabetes management. The stock experienced a significant bullish movement today.
DXCM stock is up 5.2% on Sep 3, 2024 17:25
Innovations and a robust diabetes market outlook raise investors' optimism for TNDM.
https://www.zacks.com/stock/news/2330816/reasons-to-hold-tandem-diabetes-stock-in-your-portfolio-now
SAN DIEGO, Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- The law firm of Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of DexCom, Inc.
https://www.benzinga.com/pressreleases/24/09/g40683132/dxcm-investor-deadline-robbins-geller-rudman-dowd-llp-announces-that-dexcom-inc-investors-with-sub
NEW YORK, Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. DXCM and certain of the Company's senior executives.
https://www.benzinga.com/pressreleases/24/09/g40682414/dxcm-stock-notice-dexcom-inc-is-being-sued-for-securities-fraud-contact-bfa-law-now-about-the-laws
NEW YORK, Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Do you, or did you, own shares of DexCom, Inc. DXCM? Did you purchase your shares between January 8, 2024 and July 25, 2024, inclusive? Did you lose money in your investment in DexCom, Inc.?
https://www.benzinga.com/pressreleases/24/09/g40679663/dexcom-inc-nasdaq-dxcm-deadline-alert-bernstein-liebhard-llp-reminds-dexcom-inc-investors-of-upcom
SAN FRANCISCO, Sept. 02, 2024 ( GLOBE NEWSWIRE ) -- Hagens Berman urges DexCom, Inc. DXCM investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
https://www.benzinga.com/pressreleases/24/09/g40677163/dexcom-dxcm-faces-investor-and-analyst-backlash-after-revealing-disappointing-growth-hagens-berman
Trade DexCom Inc. and 700+ other stocks, cryptocurrencies, commodities and more on Morpher. Sign up now and never miss out on the action again!